6533b7defe1ef96bd1275e52
RESEARCH PRODUCT
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development.
Bethany A. RhotenZaira PatelliUmberto TassiniFlorian ScottéChristian SimonSusanne SingerDavide MattavelliPaolo BossiNoam YaromNoam YaromPierluigi BonomoKatherine TaylorAlice MaruelliMarie FallonBarbara A. MurphyThiago Bueno De OliveiraSimon N. RogersCalogero SaievaOurania Nicolatou GatidisCristiana Bergaminisubject
Cancer Researchmedicine.medical_specialtyScoring criteriaDiseaselcsh:RC254-282Article03 medical and health sciences0302 clinical medicineQuality of lifehead and neck cancer; multimodal therapies; patient preferences; patient priorities; quality of lifeHealth caremedicineIn patient030212 general & internal medicinemultimodal therapiesneoplasmsbusiness.industryHead and neck cancermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensHead and neck squamous-cell carcinoma3. Good healthstomatognathic diseasesPatient perceptionsOncologypatient prioritiesquality of life030220 oncology & carcinogenesisFamily medicinehead and neck cancerbusinesspatient preferencesdescription
Shared-decision making for head and neck squamous cell carcinoma (HNSCC) is challenged by the difficulty to integrate the patient perception of value within the framework of a multidisciplinary team approach. The aim of this study was to develop a questionnaire to assess the preferences of HNSCC patients with respect to the disease trajectory, expected treatment, and toxicities. In accordance with the standardized EORTC Quality of Life Group&rsquo
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-11-30 |